NDC 16729-367-46 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-367
- Requested NDC
- 16729-367-46
- Package NDCs from labels
- 16729-367-10, 16729-367-15, 16729-367-16, 16729-367-17, 16729-367-45, 16729-367-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2024-11-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-367-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-367-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-367-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-367-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-367-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-367-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-367-10 | EA - Each | 16729-367 | aea7451f-249f-4002-a7df-f367e3bb0513 | 1 | 2020-09-14 |
| 16729-367-15 | EA - Each | 16729-367 | 0eff996a-5135-4a4b-a09e-70ccc66334d4 | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vaseretic | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | Bausch Health US, LLC | bf3007e2-8fcc-48de-8fd5-55e95033d62f | 2020-08-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Candesartan Cilexetil and Hydrochlorothiazide | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | f3c4f7ed-e667-4528-a675-b032c2a4425d | 2020-08-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 0fdb6713-8013-4cfe-a776-0c1e9414a91c | 2020-06-02 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Solco Healthcare U.S., LLC | 60c97ab9-b25e-4ea5-a159-792292178c65 | 2020-05-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | ScieGen Pharmaceuticals, Inc. | 02e96a51-1d56-460c-8c20-3d6f37e0ce46 | 2020-05-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Actavis Pharma, Inc. | ab5e9ae4-e575-4a63-99f3-2bde36bdd508 | 2020-05-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Aphena Pharma Solutions - Tennessee, LLC | e2903227-4a79-4a9c-b96b-073b8e41fb01 | 2020-01-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 33710c3c-6f17-457a-8665-04c23bca8b75 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | a06ee3c1-bd0d-4dda-a453-1655eebffdae | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 411caa05-5eff-4285-a940-7f6d2429ba81 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | e1f94546-c71c-4175-9384-20238181e05f | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | c5f26357-40f3-49f4-99f2-845a8dda5f39 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 1f6ab5e0-8320-4489-bed2-8c90c534e5ae | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Cool Vanilla | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | d701c221-9f68-47ff-b766-2f4f1998649f | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Amber | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 7f5e6872-4d26-410e-8afe-16a016f9a399 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Ivory | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 1124ba7d-a328-409b-8c88-e74bb3e501f5 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Honey | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 9c407dc7-fcde-4660-9a06-57bd8a6b867d | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Chestnut | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | f07e8bb2-30ae-4337-ad60-84f55f2ff354 | 2019-10-08 | Warnings | 15FIX9V2JP |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | be008c6a-6036-4abf-a3fc-450465c88d55 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Proficient Rx LP | e210f962-9b91-46c6-af8f-9f9a9ae84245 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.